Fero Industries, Inc. | FROI | Hot Stock

Fero Industries, Inc FROI

After much anticipation, our new pick is  finally here. FROI poses a unique opportunity for us to involve ourselves with a stock that is poised for rapid growth. FROI’s Sucanon nutraceutical is one of only three products in the world with approval under the category of ‘Insulin Sensitizer’, used to treat Type 2 Diabetes.

Sucanon® has been approved for prescription sale in China , Peru and Mexico (Where it is distributed over-the-counter there under an exclusive agreement with Merck S.A. de C.V.), and as of this morning’s PR, will now also be expanding its consumer base into the Middle East.

We are particularly excited about this play, not only because they have a niche in a multi-billion dollar market, but because of the ripening conditions on the chart as well.

CALGARY, Alberta , Dec. 22, 2011 /PRNewswire/ — Fero Industries, Inc. (OTCQB: FROI.PK – News), the exclusive owner, producer and distributor of the Type-II diabetes treatment Sucanon®, is pleased to announce that it has entered into a Distribution Agreement with Premium Pharma Co. for the marketing and distribution of Sucanon® in several countries in the region ( Egypt , Saudi Arabia , United Arab Emirates , Bahrain , Kuwait , Qatar , Oman , Jordan , Lebanon , Iraq , Sudan and Libya ).

 

The 5-year Distribution Agreement calls for a minimum purchase of $13 million USD and gives Premium Pharma the exclusive right to market and sell Sucanon® through its established distribution channels and will begin shortly the regulatory process with the Ministries of Health for the sale of Sucanon®. Fero is also taking the necessary steps to comply with the United States government for this Agreement, and the companies expect to complete the licencing process and commence shipping of Sucanon® within a year.
Also have a look at this FROI video chart, and take note of the fact that BARCHART is giving FROI a “Buy” Rating

More Info can be found at www.feroindustries.com

BioSante Pharmaceuticals, Inc. | BPAX

BioSante Pharmaceuticals, Inc. BPAX

BPAX continues to look better with its second consecutive day of gains. The stock hit a high of .51, and has held a good portion of that gain heading into the close, on more than 3x the 3mo. average volume.

We’ve stated, even just this morning, that BPAX is going to provide folks with some good opportunities moving forward as it continues to recover from a monumental pullback these past few weeks. We’ve been proven right for the second day running.

Again, a reminder to be on a sharp lookout for our newsletter tomorrow, as it will include a brand new pick that has us really excited. 

It is a sub-penny play with one of only three herbal nutraceutical products approved anywhere for insulin sensitization. This company is operating in a multi-billion dollar sector, and appears to be poised for astronomical growth.  It recently has bounced off of its 52-week low, and is making higher lows since then. Tune in tomorrow for the symbol.

APP, BPAX – Today’s Stocks

American Apparel, Inc. APP

APP ran into a patch of resistance at .75 this past Friday, and once again this week. It seems that this level is going to be a major hurdle for us to get over, but following a breakthrough, there appears to be relatively little resistance until around .85.

Looking forward a bit, it is going to be very interesting when the quarterly numbers for this retailer’s holiday season come in. This stock will be on our watchlist at least until that time.

BioSante Pharmaceuticals, Inc. BPAX

BPAX saw its first breath of life coming off of its bottom yesterday, as we are now starting to see signs of recovery. Yesterday was the stock’s first green session since it fell off of a cliff of late, but we are now seeing accumulation at this low level, which excites us with the possibility that a snap of gains may be forthcoming.

The trouble started for BPAX after a less-than-favorable testing outcome for one of the company’s products, Libigel. The ground may still be a little shaky with this play, but the bottom-line? We want to be around when this stock’s recovery reaches full-swing.

EXTO, VHGI, DGHG – Today’s Stocks

Exit Only, Inc. EXTO

On more than one occasion (probably more than ten occasions, actually) we have stated that EXTO has been one of our favorite plays of the past six months or so, providing total gains of well over 600%

We have reached another point where it seems the EXTO chart is heating up on its way to excellent trading conditions. It would appear that BARCHART.COM agrees with that assessment, as they are currently listing EXTO with a “Buy” Rating.

Diversified Global Holdings Group, Inc. DGHG

& VHGI Holdings, Inc. VHGI

Both of these stocks experienced runs following our initial alerts, and both are currently bouncing around after having found higher levels of support, so we thought we’d mention them in the same breath today.

These are two more stocks that have helped to make 2011 one of our most successful years ever. Whether you’ve been with us the whole time, or are just joining our ranks, it seems we have gone above and beyond, and its only going to get better from here.

Just a reminder, we have a new pick coming on Thursday, so be sure to be on the lookout.

APP, BPAX, GRDO – Today’s Stocks

American Apparel, Inc. APP

APP hit a high of of .75 on Friday before closing strong at .72, bringing our total gains on this play to roughly 50%

There was also news out this morning:

LOS ANGELES, Dec. 19, 2011 /PRNewswire via COMTEX/ — American Apparel (Amex: APP), the vertically integrated clothing manufacturer based in downtown Los Angeles, announces the opening of two more shop-in-shops inside Selfridges, one of London’s most famous and respected department stores. The new locations in Manchester and Birmingham follow the ongoing success of the American Apparel concession at Selfridges, London which opened in 2010.

BioSante Pharmaceuticals, Inc. BPAX

BPAX showed up on our radar Friday, as we stated that we were observing diligently for a bottom to form following a serious dive that still seems to have some downward momentum.

The key here will still be the timing of the upswing, which often takes patience in these instances. We aren’t getting trigger-happy yet, as we know that these things take time, and the payoff can be more than worth the wait.

Guard Dog, Inc. GRDO

We mentioned last week that we’d like to see the support hold at .0006, which it did. We are looking to break a barrier of resistance at .0009 for it to then contest the highs it saw this past summer.

Get Our FREE Daily Reports!

SUBSCRIBE